Mohamed Teleb

1.5k total citations
77 papers, 1.1k citations indexed

About

Mohamed Teleb is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Mohamed Teleb has authored 77 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 26 papers in Organic Chemistry and 21 papers in Oncology. Recurrent topics in Mohamed Teleb's work include Synthesis and biological activity (15 papers), Peptidase Inhibition and Analysis (14 papers) and Nanoparticle-Based Drug Delivery (9 papers). Mohamed Teleb is often cited by papers focused on Synthesis and biological activity (15 papers), Peptidase Inhibition and Analysis (14 papers) and Nanoparticle-Based Drug Delivery (9 papers). Mohamed Teleb collaborates with scholars based in Egypt, United States and Saudi Arabia. Mohamed Teleb's co-authors include Marwa M. Abu‐Serie, Sherine N. Khattab, Ahmed O. Elzoghby, Adnan A. Bekhit, Mohammed Salah Ayoup, Hamida Abdel‐Hamid, Maged W. Helmy, Assem Barakat, Hesham Fahmy and Kadria A. Elkhodairy and has published in prestigious journals such as Scientific Reports, Chemical Engineering Journal and International Journal of Molecular Sciences.

In The Last Decade

Mohamed Teleb

74 papers receiving 1.1k citations

Peers

Countries citing papers authored by Mohamed Teleb

Since Specialization

Citations

This map shows the geographic impact of Mohamed Teleb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed Teleb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed Teleb more than expected).

Fields of papers citing papers by Mohamed Teleb

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamed Teleb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed Teleb. The network helps show where Mohamed Teleb may publish in the future.

Co-authorship network of co-authors of Mohamed Teleb

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamed Teleb. A scholar is included among the top collaborators of Mohamed Teleb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamed Teleb. Mohamed Teleb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ultrasmall lactoferrin/lipid multicompartmental nanomedicine-based reprogramming of glycolysis in triple-negative breast cancer via HDAC6/LDH axis enhances cancer immunotherapy 2025 ·Chemical Engineering Journal ·Islam A. Hassanin, Hesham Saeed, (unknown), (unknown), (unknown), Mona A. Abdelmoneem, Mohamed Teleb, (unknown), Sherine N. Khattab, Kadria A. Elkhodairy, Ahmed O. Elzoghby	1
2	Unveiling the structural aspects of novel azo-dyes with promising anti-virulence activity against MRSA: a deep dive into the spectroscopy via integrated experimental and computational approaches 2025 ·RSC Advances ·(unknown), (unknown), Alaa Abouelfetouh, Mohamed Teleb, Sherine N. Khattab, Nesreen S. Haiba	2
3	Triggering Breast Cancer Apoptosis via Cyclin-Dependent Kinase Inhibition and DNA Damage by Novel Pyrimidinone and 1,2,4-Triazolo[4,3-a]pyrimidinone Derivatives 2024 ·ACS Omega ·(unknown), Yeldez El Kilany, Laila F. Awad, Saied M. Soliman, Assem Barakat, (unknown), Marwa M. Abu‐Serie, Matti Haukka, Amira F. El‐Yazbi, Mohamed Teleb	2
4	Standardized Eucalyptus maculata (Corymbia maculata) Resin Extract: Metabolomic Profiling, In Vitro and In Silico Study of Anti‐HSV Activity 2024 ·Chemistry & Biodiversity ·(unknown), (unknown), Mohamed Teleb, (unknown)	1
5	Tailored design of pH-responsive microbeads for oral delivery of lactoferrin nanotherapeutics of colon cancer 2024 ·Journal of Drug Delivery Science and Technology ·(unknown), Sherine N. Khattab, Lamia Heikal, Mohamed Teleb, Doaa A. Ghareeb, Shaymaa A. Abdulmalek, (unknown), (unknown), Sanaa A. El‐Gizawy	2
6	New spiro-indeno[1,2- b ]quinoxalines clubbed with benzimidazole scaffold as CDK2 inhibitors for halting non-small cell lung cancer; stereoselective synthesis, molecular dynamics and structural insights 2023 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Assem Barakat, (unknown), Abdullah Mohammed Al‐Majid, (unknown), Matti Haukka, Marwa M. Abu‐Serie, Luís R. Domingo, Sajda Ashraf, Zaheer Ul‐Haq, Mohamed S. Nafie, Mohamed Teleb	10
7	Engineered Sericin-Tagged Layered Double Hydroxides for Combined Delivery of Pemetrexed and ZnO Quantum Dots as Biocompatible Cancer Nanotheranostics 2023 ·ACS Omega ·(unknown), Sherine N. Khattab, Shaker Ebrahim, Kadria A. Elkhodairy, Mohamed Teleb, Adnan A. Bekhit, Marwa A. Sallam, Ahmed O. Elzoghby	20
8	Reinvestigation of Passerini and Ugi scaffolds as multistep apoptotic inducers via dual modulation of caspase 3/7 and P53-MDM2 signaling for halting breast cancer 2023 ·RSC Advances ·Mohammed Salah Ayoup, (unknown), Hamida Abdel‐Hamid, Marwa M. Abu‐Serie, Sherif Ramadan, Assem Barakat, Mohamed Teleb, Magda M. F. Ismail	5
9	Battling colorectal cancer via s-triazine-based MMP-10/13 inhibitors armed with electrophilic warheads for concomitant ferroptosis induction; the first-in-class dual-acting agents 2023 ·Bioorganic Chemistry ·(unknown), Sherine N. Khattab, Nesreen S. Haiba, (unknown), Marwa M. Abu‐Serie, Mohamed Teleb	5
10	Optimized spirooxindole-pyrazole hybrids targeting the p53-MDM2 interplay induce apoptosis and synergize with doxorubicin in A549 cells 2023 ·Scientific Reports ·Mohammad Shahidul Islam, Abdullah Mohammed Al‐Majid, Essam Nageh Sholkamy, Assem Barakat, Maurizio Viale, Paola Menichini, (unknown), Fabrizio Loiacono, Mohammad Azam, Ved Prakash Verma, Sammer Yousuf, Mohamed Teleb	18
11	Harnessing ROS-Induced Oxidative Stress for Halting Colorectal Cancer via Thiazolidinedione-Based SOD Inhibitors 2022 ·ACS Omega ·(unknown), El Sayed H. El Ashry, Laila F. Awad, (unknown), Marwa M. Abu‐Serie, Mohamed Teleb	6
12	Sequential Delivery of Novel Triple Drug Combination via Crosslinked Alginate/Lactoferrin Nanohybrids for Enhanced Breast Cancer Treatment 2022 ·Pharmaceutics ·(unknown), Marwa A. Sallam, Mona A. Abdelmoneem, Mohamed Teleb, Kadria A. Elkhodairy, Adnan A. Bekhit, Asmaa F. Khafaga, Ahmed E. Noreldin, Ahmed O. Elzoghby, Sherine N. Khattab	9
13	Nature-inspired new isoindole-based Passerini adducts as efficient tumor-selective apoptotic inducers via caspase-3/7 activation 2022 ·European Journal of Medicinal Chemistry ·Mohammed Salah Ayoup, (unknown), Hamida Abdel‐Hamid, Marwa M. Abu‐Serie, (unknown), Mohamed Teleb	11
14	Bioprocess development for biosurfactant production by Natrialba sp. M6 with effective direct virucidal and anti-replicative potential against HCV and HSV 2022 ·Scientific Reports ·(unknown), Marwa M. Abu‐Serie, (unknown), Hanan A. Ghozlan, Soraya A. Sabry, Nadia A. Soliman, Mohamed Teleb, Yasser R. Abdel-Fattah	8
15	A novel ‘smart’ PNIPAM-based copolymer for breast cancer targeted therapy: Synthesis, and characterization of dual pH/temperature-responsive lactoferrin-targeted PNIPAM-co-AA 2021 ·Colloids and Surfaces B Biointerfaces ·(unknown), Mona A. Abdelmoneem, Nesreen S. Haiba, (unknown), Mohamed Teleb, Ahmed O. Elzoghby, Asmaa F. Khafaga, Ahmed E. Noreldin, Fernando Alberício, Sherine N. Khattab	50
16	Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy 2020 ·Colloids and Surfaces B Biointerfaces ·(unknown), Adnan A. Bekhit, Sherine N. Khattab, Maged W. Helmy, (unknown), Mohamed Teleb, Ahmed O. Elzoghby	84
17	Structure-based design and optimization of pyrimidine- and 1,2,4-triazolo[4,3-a]pyrimidine-based matrix metalloproteinase-10/13 inhibitors via Dimroth rearrangement towards targeted polypharmacology 2020 ·Bioorganic Chemistry ·El Sayed H. El Ashry, Laila F. Awad, Mohamed Teleb, (unknown), Marwa M. Abu‐Serie, (unknown)	35
18	100 years of sickle cell disease research: etiology, pathophysiology and rational drug design (part 1) 2019 ·Beni-Suef University Journal of Basic and Applied Sciences ·Mona A. Mahran, Mohamed Teleb, Elwy H. Abdelkader	0
19	Synthesis of some new C2 substituted dihydropyrimidines and their electrophysiological evaluation as L-/T-type calcium channel blockers 2019 ·Bioorganic Chemistry ·Mohamed Teleb, Ola H. Rizk, Fang‐Xiong Zhang, Frank R. Fronczek, Gerald W. Zamponi, Hesham Fahmy	11
20	Battle tactics against MMP-9; discovery of novel non-hydroxamate MMP-9 inhibitors endowed with PI3K/AKT signaling attenuation and caspase 3/7 activation via Ugi bis-amide synthesis 2019 ·European Journal of Medicinal Chemistry ·Mohammed Salah Ayoup, (unknown), Hamida Abdel‐Hamid, El Sayed Ramadan, Marwa M. Abu‐Serie, (unknown), Mohamed Teleb	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact